GO:0097734 extracellular exosome biogenesis: Vesicle Assembly Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097734 extracellular exosome biogenesis describes the assembly and secretion of exosomes, membrane-bounded vesicles released when multivesicular body membranes fuse with the plasma membrane.
• Exosome biogenesis proceeds through endosomal sorting complex required for transport (ESCRT)-dependent and ESCRT-independent routes that generate intraluminal vesicles within multivesicular bodies.
• Key molecular players include Rab GTPases, ESCRT components, syntenin, ALIX, tetraspanins, sphingomyelinases, and ceramide-producing enzymes.
• Dysregulated exosome biogenesis contributes to cancer metastasis, neurodegeneration, and immune modulation, making it a therapeutic target.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of exosome biogenesis genes.
• Studying this process requires complementary methods such as nanoparticle tracking analysis, electron microscopy, proteomics, and CRISPR library screening.
Description
Extracellular exosome biogenesis (GO:0097734) is the biological process by which cells assemble and secrete exosomes, small membrane-bounded vesicles that originate from the endosomal system and are released into the extracellular space. This process is fundamental to intercellular communication because exosomes carry proteins, lipids, and nucleic acids that can alter the behavior of recipient cells. Understanding exosome biogenesis is therefore central to cell biology, immunology, and cancer research. The term encompasses the formation of intraluminal vesicles (ILVs) within multivesicular bodies (MVBs), the trafficking of MVBs to the plasma membrane, and the fusion event that releases exosomes. Multiple molecular machines, including the ESCRT machinery, Rab GTPases, and lipid-modifying enzymes, coordinate these steps. Because exosome biogenesis is dysregulated in many diseases, researchers increasingly rely on CRISPR-based models to determine which genes are causally involved. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0097734, its mechanisms, key genes, disease links, and experimental strategies.
extracellular exosome biogenesis At A Glance
| GO ID | GO:0097734 |
|---|---|
| GO term | extracellular exosome biogenesis |
| Ontology | biological_process |
| Synonym | exosome assembly or secretion; exosome biogenesis; exosome production; ILV assembly; intraluminal vesicle assembly |
| Major function | Assembly and secretion of exosomes from multivesicular bodies to the extracellular space |
| Cellular location | Multivesicular body, endosomal membrane, plasma membrane |
| Key machinery | ESCRT complexes, Rab GTPases, syntenin, ALIX, tetraspanins, sphingomyelinases |
| Related process | Endosomal sorting, intraluminal vesicle formation, membrane fusion |
What Is GO:0097734?
According to the Gene Ontology, GO:0097734 extracellular exosome biogenesis is defined as the assembly and secretion of an extracellular exosome, a membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. In simpler terms, it is the entire cellular process that builds exosomes inside endosomes and then exports them outside the cell.
Why Is extracellular exosome biogenesis Important in Cell Biology?
Extracellular exosome biogenesis is important because exosomes mediate intercellular communication in normal physiology and disease, and their cargo can reprogram recipient cells. Dysregulation of this process is linked to cancer progression, metastasis, neurodegeneration, and immune disorders. Therefore, understanding GO:0097734 provides mechanistic insight into how cells package and release signals, and it offers opportunities for biomarker discovery and therapeutic intervention.
• Exosomes transfer proteins, lipids, and RNAs between cells, influencing gene expression and signaling in recipients.
• Exosome biogenesis is hijacked in cancer to promote metastasis and immune evasion.
• Neurodegenerative diseases involve altered exosome secretion that contributes to protein aggregation spread.
• Exosomes are promising biomarkers because their cargo reflects the cell of origin.
• The process is a target for engineering exosomes as drug delivery vehicles.
• ESCRT-dependent and ESCRT-independent pathways provide multiple entry points for therapeutic modulation.
• Rab GTPases and lipid enzymes regulate exosome secretion and are potential drug targets.
• CRISPR screens can identify novel regulators of exosome biogenesis.
• Understanding biogenesis is essential for standardizing exosome-based diagnostics.
• Exosome biogenesis intersects with autophagy and endosomal trafficking, affecting cellular homeostasis.
What Happens During extracellular exosome biogenesis?
Endosomal Sorting and Intraluminal Vesicle Formation
In simple terms: The cell sorts proteins and lipids into small inward buds inside endosomes.
Exosome biogenesis begins with the inward budding of the endosomal membrane to form intraluminal vesicles (ILVs) within multivesicular bodies (MVBs). This step requires the ESCRT machinery, which recognizes ubiquitinated cargo and drives membrane deformation. ESCRT-0, -I, -II, and -III complexes sequentially act to concentrate cargo and scission of ILVs. Alternatively, ESCRT-independent pathways involving tetraspanins, ceramide, and sphingomyelinases can also generate ILVs.
Cargo Selection and Sorting
In simple terms: Specific proteins and RNAs are selected to go into exosomes.
Cargo sorting into ILVs is selective and mediated by signals such as ubiquitination, lipid microdomains, and adaptor proteins like syntenin and ALIX. Tetraspanins such as CD9, CD63, and CD81 are enriched on exosomes and contribute to cargo organization. RNA-binding proteins can direct miRNAs and mRNAs into exosomes, influencing the functional output of secreted vesicles.
Multivesicular Body Maturation and Trafficking
In simple terms: The vesicle-filled endosome moves to the cell surface.
After ILV formation, MVBs mature and are transported along cytoskeletal tracks to the plasma membrane. Rab GTPases, particularly Rab27a and Rab27b, regulate MVB docking and fusion. Other Rab proteins and their effectors coordinate the spatial and temporal control of MVB trafficking.
Fusion with the Plasma Membrane and Exosome Release
In simple terms: The endosome fuses with the outer membrane and releases exosomes.
The limiting membrane of the MVB fuses with the plasma membrane, releasing ILVs as exosomes into the extracellular space. This fusion event is mediated by SNARE proteins and regulated by calcium and Rab GTPases. Once released, exosomes can travel to recipient cells and deliver their cargo.
Regulation by ESCRT-Dependent and ESCRT-Independent Pathways
In simple terms: There are multiple ways to make exosomes, some using ESCRT and some not.
ESCRT-dependent biogenesis relies on the sequential action of ESCRT complexes to sort cargo and form ILVs. ESCRT-independent mechanisms involve lipid rafts, ceramide generated by neutral sphingomyelinase 2, and tetraspanin-enriched microdomains. The balance between these pathways can vary by cell type and physiological state, affecting exosome composition and function.
Key Genes Involved in GO:0097734 extracellular exosome biogenesis
The following genes and proteins are central to extracellular exosome biogenesis, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESCRT-0 (HGS, STAM) | Cargo recognition and sorting | Knockout reduces exosome secretion |
| ESCRT-I (TSG101) | ILV formation and cargo sorting | Common target for KO studies |
| ESCRT-II (EAP30) | Membrane deformation | Less studied but essential |
| ESCRT-III (CHMP4) | Membrane scission | Dominant-negative mutants block exosome release |
| ALIX (PDCD6IP) | Cargo sorting and ESCRT recruitment | Knockout affects exosome composition |
| Syntenin (SDCBP) | Adaptor for cargo and ESCRT | Overexpression increases exosome production |
| Rab27a | MVB docking and fusion | Knockdown reduces exosome release |
| Rab27b | MVB trafficking | Isoform-specific functions |
| Rab11 | Endosomal recycling | Regulates MVB dynamics |
| CD9 | Tetraspanin, ESCRT-independent pathway | Knockout alters exosome cargo |
| CD63 | Tetraspanin marker | Used for exosome detection |
| CD81 | Tetraspanin | Involved in cargo sorting |
| nSMase2 (SMPD3) | Ceramide production | Inhibitor GW4869 blocks exosome release |
| GPR143 | ESCRT-dependent exosome biogenesis | Promotes cancer metastasis |
| VPS4 | ESCRT disassembly | Dominant-negative blocks exosome secretion |
| TSG101 | ESCRT-I component | Knockout impairs exosome biogenesis |
| HRS | ESCRT-0 component | Knockdown reduces exosome secretion |
How Is extracellular exosome biogenesis Regulated?
Exosome biogenesis is regulated at multiple levels, including transcriptional control of ESCRT components, post-translational modifications, and signaling pathways such as mTOR and the integrated stress response. Rab GTPases and their effectors provide spatial regulation, while lipid-modifying enzymes like nSMase2 control ceramide-dependent ILV formation. Calcium signaling and SNARE proteins regulate the final fusion step. Additionally, oncogenic signaling can upregulate exosome production, as seen with GPR143 in cancer.
extracellular exosome biogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR143 | Cancer metastasis | Knockout in cancer cell lines |
| Rab27a | Melanoma progression | Knockdown or knockout |
| nSMase2 | Neurodegeneration | Inhibitor treatment or knockout |
| TSG101 | Cancer and viral budding | Knockout in HEK293 |
| CD63 | Cancer biomarker | Knock-in with fluorescent tag |
Cancer Progression and Metastasis
Exosomes secreted via GO:0097734 can promote tumor growth, angiogenesis, and metastasis by transferring oncogenic proteins and RNAs to recipient cells. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis, highlighting a direct link between this process and malignancy. Targeting exosome biogenesis is therefore a potential therapeutic strategy.
Neurodegenerative Diseases
In neurodegenerative disorders, exosomes can spread misfolded proteins such as amyloid-beta and alpha-synuclein between neurons. Dysregulation of exosome biogenesis contributes to disease progression, and modulating this pathway may reduce pathology.
Immune Regulation and Inflammation
Exosomes released through this process can modulate immune responses by delivering antigens and regulatory RNAs to immune cells. This has implications for autoimmune diseases and cancer immunotherapy.
From extracellular exosome biogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate exosome secretion? | CRISPR knockout in HEK293 or HeLa |
| Does mutation Y affect exosome cargo? | Point mutation knock-in |
| Can we track exosomes in live cells? | Tagged knock-in (e.g., CD63-GFP) |
| Does overexpression increase exosome production? | Overexpression stable cell line |
| Which genes are essential for exosome biogenesis? | CRISPR library screening |
| How does gene X affect exosome protein composition? | Knockout followed by proteomics |
How to Study the extracellular exosome biogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Nanoparticle tracking analysis | Size and concentration of exosomes | Quantify secretion changes |
| Transmission electron microscopy | Morphology of exosomes and MVBs | Validate biogenesis defects |
| Western blot | Exosome marker proteins | Confirm purity and cargo |
| Proteomics | Protein composition of exosomes | Identify cargo alterations |
| CRISPR library screening | Genes affecting exosome biogenesis | Discover novel regulators |
| Flow cytometry | Tetraspanin markers on exosomes | High-throughput analysis |
| RNA sequencing | RNA cargo in exosomes | Study RNA sorting mechanisms |
Nanoparticle Tracking Analysis (NTA)
NTA measures the size and concentration of exosomes in conditioned media, providing quantitative assessment of secretion. It is widely used to compare exosome release between control and CRISPR-edited cells.
Electron Microscopy
Electron microscopy visualizes exosome morphology and multivesicular body ultrastructure, confirming defects in ILV formation. Immunoelectron microscopy can localize specific markers.
Proteomics and Mass Spectrometry
Proteomic analysis of purified exosomes identifies cargo changes upon gene knockout or overexpression, revealing pathways affected by exosome biogenesis regulators.
CRISPR Library Screening
Genome-wide CRISPR screens can identify novel genes required for exosome biogenesis and secretion, as demonstrated for GPR143 and other regulators.
How CRISPR Can Be Used to Study GO:0097734 extracellular exosome biogenesis
Knockout
CRISPR knockout of genes such as TSG101, Rab27a, or GPR143 abolishes or reduces exosome secretion, providing causal evidence for their role in GO:0097734. Knockout cell lines are essential for validating candidate regulators identified in screens.
Point Mutation
Point mutations can dissect domain-specific functions, for example in ESCRT components or Rab GTPases, without completely eliminating protein expression. This approach reveals residues critical for exosome biogenesis.
Knock-in
Knock-in of fluorescent tags such as CD63-GFP allows real-time tracking of exosome biogenesis and secretion in live cells. Tagged knock-in models are valuable for imaging and isolation.
Overexpression
Overexpression of genes like syntenin or Rab27a increases exosome production, enabling gain-of-function studies. Overexpression models help determine sufficiency of a gene to drive biogenesis.
How EDITGENE Supports extracellular exosome biogenesis Research
Researchers studying extracellular exosome biogenesis-related genes often need to determine whether a candidate gene is causally involved in vesicle assembly, cargo sorting, or secretion. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process, from knockout to library screening.
Contact EDITGENE today to design your custom CRISPR model for extracellular exosome biogenesis research.
Frequently Asked Questions About extracellular exosome biogenesis
What is extracellular exosome biogenesis?
It is the cellular process of assembling and secreting exosomes, small vesicles released from multivesicular bodies, as defined by GO:0097734.
What genes are involved in extracellular exosome biogenesis?
Key genes include ESCRT components (TSG101, CHMP4), Rab GTPases (Rab27a, Rab27b), syntenin, ALIX, tetraspanins (CD9, CD63, CD81), and nSMase2.
What is the GO ID for extracellular exosome biogenesis?
The GO ID is GO:0097734.
How are exosomes formed?
Exosomes form through inward budding of the endosomal membrane to create intraluminal vesicles within multivesicular bodies, which then fuse with the plasma membrane to release exosomes.
What is the difference between ESCRT-dependent and ESCRT-independent exosome biogenesis?
ESCRT-dependent biogenesis uses the ESCRT machinery for cargo sorting and membrane scission, while ESCRT-independent pathways rely on lipids like ceramide and tetraspanins.
Which diseases are linked to exosome biogenesis?
Cancer, neurodegenerative diseases, and immune disorders are linked to dysregulated exosome biogenesis.
How can CRISPR be used to study exosome biogenesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in exosome assembly and secretion.
What methods measure exosome secretion?
Nanoparticle tracking analysis, electron microscopy, Western blot, and proteomics are commonly used to measure exosome secretion and composition.
What is the role of Rab27a in exosome biogenesis?
Rab27a regulates the docking and fusion of multivesicular bodies with the plasma membrane, and its knockdown reduces exosome release.
Can exosome biogenesis be targeted therapeutically?
Yes, inhibiting key regulators like GPR143 or nSMase2 has shown potential in cancer and neurodegeneration models.
Conclusion
GO:0097734 extracellular exosome biogenesis is a fundamental biological process that governs the assembly and secretion of exosomes, with broad implications for cell communication, cancer, and neurodegeneration. Understanding its molecular machinery, including ESCRT components and Rab GTPases, provides a foundation for therapeutic targeting and biomarker development. CRISPR-based models are indispensable for dissecting the causal roles of individual genes in this pathway.
References
- 1. Gurung S et al.. 2021. The exosome journey: from biogenesis to uptake and intracellular signalling.. Cell Commun Signal 19(1):47 PMID: 33892745
- 2. Arya SB et al.. 2024. The ins-and-outs of exosome biogenesis, secretion, and internalization.. Trends Cell Biol 34(2):90-108 PMID: 37507251
- 3. Colombo M et al.. 2014. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.. Annu Rev Cell Dev Biol 30:255-89 PMID: 25288114
- 4. Lee YJ et al.. 2023. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.. Dev Cell 58(4):320-334.e8 PMID: 36800996
- 5. Han QF et al.. 2022. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer.. Mol Cancer 21(1):207 PMID: 36320056
- 6. Kalluri R et al.. 2020. The biology, function, and biomedical applications of exosomes.. Science 367(6478) PMID: 32029601
- 7. van Niel G et al.. 2018. Shedding light on the cell biology of extracellular vesicles.. Nat Rev Mol Cell Biol 19(4):213-228 PMID: 29339798
- 8. Hessvik NP et al.. 2018. Current knowledge on exosome biogenesis and release.. Cell Mol Life Sci 75(2):193-208 PMID: 28733901
